EP3227675
AKTIVÍN-ACTRII MÓTLYF OG NOTKUN TIL MEÐHÖNDLUNAR Á MERGRANGVAXTARHEILKENNUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.12.2015EP published:
15.3.2023EP application number:
15865213.1
EP translation filed:
24.5.2023Grant published:
15.6.2023EPO information:
European Patent Register
Max expiry date:
2.12.2035Expiry date:
2.12.2026Next due date:
31.12.2026
Title in English:
ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING MYELODYSPLASTIC SYNDROMELanguage of the patent:
English
Timeline
Today
3.12.2015EP application
15.3.2023EP Publication
24.5.2023Translation submitted
15.6.2023Registration published
2.12.2026Expires
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Name:
Acceleron Pharma Inc.Address:
128 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
ATTIE, Kenneth M.Address:
Boston, MA 02116, US
Name:
ROVALDI, ChristopherAddress:
Swampscott, MA 01907, US
Name:
LAADEM, AbderrahmaneAddress:
Belle Mead, NJ 08502, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201462086977 PDate:
3.12.2014Country:
US
Number:
201462088478 PDate:
5.12.2014Country:
US
Number:
201562153872 PDate:
28.4.2015Country:
US
Number:
201562173782 PDate:
10.6.2015Country:
US
Number:
201562218728 PDate:
15.9.2015Country:
US
Classification
Categories:
A61K 38/17, C07K 14/71, G01N 33/49, A61P 7/00, A61P 7/06, A61P 35/02, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 15.11.2023
Expires: 2.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.11.2024
Expires: 2.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.12.2025
Expires: 2.12.2026
Payer: Árnason Faktor ehf.